Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Clinical trial NCT05274048 · RECRUITING

Trial details

NCT number: NCT05274048
Sponsor: Fox Chase Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Gastrointestinal Cancer HER2 Gene Mutation

Start date: 2022-06-24
Primary completion: 2026-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.